Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Vet Dermatol ; 22(1): 31-8, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20723188

RESUMO

Zinc deficiency causes skin diseases both in humans and in animals. The underlying pathogenic mechanisms remain unclear, but a growing body of evidence indicates a role for zinc in skin protection against free radical-induced oxidative damage. The immunohistochemical expression of heat shock proteins (HSPs; Hsp27, Hsp72, Hsp73 and Hsp90), Cu/Zn superoxide dismutase (SOD), metallothionein (MT), Ki-67 antigen and active caspase-3 were evaluated in normal canine skin and in samples from eight dogs with zinc-responsive dermatosis. All investigated HSPs showed intense cytoplasmic immunostaining in the affected epidermis. Focal nuclear positivity of Hsp72 was also detected in keratinocytes. Although Cu/Zn SOD expression was similar to that observed in normal skin, MT immunoreactivity occurred in both the cytoplasm and the nucleus of basal cells in normal skin but was absent from the affected epidermis. Caspase-3 activation was also absent in the involved epidermis, which revealed a high Ki-67 index (a 3.5- to 9-fold increase compared with normal skin). These results support the hypothesis that cellular response to stress, particularly oxidative stress, is involved in the pathogenesis of skin lesions in canine zinc-responsive dermatosis. The lack of MT immunoreactivity in the affected epidermis may be indicative of low zinc levels, thus resulting in vulnerability to oxidative damage. In contrast, high expression levels of HSPs in skin during zinc deficiency may confer protection against a variety of dangerous stimuli, contributing to inhibition of apoptosis and to cell cycle regulation of proliferating keratinocytes.


Assuntos
Dermatite/veterinária , Doenças do Cão/metabolismo , Estresse Oxidativo/fisiologia , Zinco/uso terapêutico , Animais , Dermatite/tratamento farmacológico , Dermatite/metabolismo , Doenças do Cão/tratamento farmacológico , Cães , Células Epidérmicas , Epiderme/metabolismo , Regulação da Expressão Gênica , Proteínas de Choque Térmico/genética , Proteínas de Choque Térmico/metabolismo , Imuno-Histoquímica , Queratinócitos/metabolismo , Metalotioneína/genética , Metalotioneína/metabolismo , Superóxido Dismutase/genética , Superóxido Dismutase/metabolismo
2.
J Vet Diagn Invest ; 32(6): 964-967, 2020 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-33000710

RESUMO

A 7-y-old mixed-breed male dog was presented with a history of generalized lymphadenopathy. Fine-needle aspirates of the enlarged peripheral lymph nodes were suggestive of lymphoma. Histologic examination of a retromandibular lymph node was suggestive of high-grade, medium large-cell lymphoma. Immunohistochemistry revealed concurrent expression of CD3 and CD20. The co-localization of the 2 antigens was confirmed by immunofluorescence. PCR for antigen receptor gene rearrangements (PARR) detected clonal rearrangements for both T-cell receptor gamma and B-cell receptor. The final diagnosis was CD3-CD20-positive anaplastic lymphoma with cross-lineage rearrangement.


Assuntos
Antígenos CD20/genética , Complexo CD3/genética , Doenças do Cão/diagnóstico , Doenças do Cão/genética , Rearranjo Gênico , Linfoma Difuso de Grandes Células B/veterinária , Animais , Antígenos CD20/metabolismo , Complexo CD3/metabolismo , Doenças do Cão/fisiopatologia , Cães , Imunofluorescência/veterinária , Imuno-Histoquímica , Linfonodos/patologia , Linfoma Difuso de Grandes Células B/diagnóstico , Linfoma Difuso de Grandes Células B/genética , Linfoma Difuso de Grandes Células B/fisiopatologia , Masculino
3.
BMC Vet Res ; 2: 37, 2006 Dec 27.
Artigo em Inglês | MEDLINE | ID: mdl-17192191

RESUMO

BACKGROUND: Prion diseases are characterised by a neurodegenerative pattern in which the function of immune system remains still elusive. In the present study, we evaluate if an exogenous treatment with Interleukin-12 (IL-12) and IL-18, able to activate microglia, is able to affect scrapie pathogenesis. RESULTS: Cytokines injected intracranially, induced a strong inflammatory response characterised by TNF-alpha production and microglia activation. Two groups of mice were injected intracerebrally with high dose of ME7 strain of scrapie containing IL-12 and IL-18 or sterile saline. Cytokines-treated mice showed a more pronounced accumulation of PrPSc in brain tissues at 90 days post-inoculation and a shorter mean survival times than untreated mice. CONCLUSION: We can conclude that intracerebral administration of IL-12 and IL-18 can modulate scrapie pathogenesis possibly through a microglia-mediated pattern.


Assuntos
Interleucina-12/administração & dosagem , Interleucina-12/uso terapêutico , Interleucina-18/administração & dosagem , Interleucina-18/uso terapêutico , Scrapie/tratamento farmacológico , Animais , Quimioterapia Combinada , Feminino , Injeções Intraventriculares , Interferon gama/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Fatores de Tempo , Fator de Necrose Tumoral alfa/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA